Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Hughes

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Statistics in Medicine|September 30, 1993
Reporting Bayesian analyses of clinical trialsM D Hughes
Statistics in Medicine|May 30, 1993
Stopping guidelines for clinical trials with multiple treatmentsM D Hughes
Bender'S Health Care Law Monthly|March 8, 1998
U.S. Department of Labor enters the fray of health care consumer protectionM D Hughes
Statistics in Medicine|April 30, 1997
Power considerations for clinical trials using multivariate time-to-event dataM D Hughes
Biometrics|December 1, 1993
Regression dilution in the proportional hazards modelM D Hughes
Statistics in Medicine|December 13, 2000
Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trialsM D Hughes
Biometrics|September 18, 1997
Assessing the effects of interventions using longitudinal data with samples subject to selectionH M Lin, M D Hughes
Statistics in Medicine|June 1, 1990
Estimation issues in clinical trials and overviewsS J Pocock, M D Hughes
Biometrics|September 1, 1995
Use of historical marker data for assessing treatment effects in phase I/II trials when subject selection is determined by baseline marker levelH M Lin, M D Hughes
Statistics in Medicine|October 15, 1996
Analysis of uncontrolled treatment changes in HIV clinical trailsH M Lin, M D Hughes
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|September 30, 1993
Reporting Bayesian analyses of clinical trialsM D Hughes
Statistics in Medicine|May 30, 1993
Stopping guidelines for clinical trials with multiple treatmentsM D Hughes
Bender'S Health Care Law Monthly|March 8, 1998
U.S. Department of Labor enters the fray of health care consumer protectionM D Hughes
Statistics in Medicine|April 30, 1997
Power considerations for clinical trials using multivariate time-to-event dataM D Hughes
Biometrics|December 1, 1993
Regression dilution in the proportional hazards modelM D Hughes
Statistics in Medicine|December 13, 2000
Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trialsM D Hughes
Biometrics|September 18, 1997
Assessing the effects of interventions using longitudinal data with samples subject to selectionH M Lin, M D Hughes
Statistics in Medicine|June 1, 1990
Estimation issues in clinical trials and overviewsS J Pocock, M D Hughes
Biometrics|September 1, 1995
Use of historical marker data for assessing treatment effects in phase I/II trials when subject selection is determined by baseline marker levelH M Lin, M D Hughes
Statistics in Medicine|October 15, 1996
Analysis of uncontrolled treatment changes in HIV clinical trailsH M Lin, M D Hughes
Pageof 8